Delorbis Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Salutas Pharma

Poland

All drugs from this manufacturer

  • RUNAPLAX

    This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 2.5 mg

    ATC: B01AF01